Quantcast

Latest Cystic fibrosis Stories

2014-10-15 08:30:43

NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct. 15, 2014 /PRNewswire-USNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that the National Institutes of Health (NIH) has awarded up to $15.6 million over 5 years in grants to The University of North Carolina, Chapel Hill (UNC-CH) and The University of Colorado, Denver (UCD) to conduct research...

2014-10-09 08:28:30

SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- OrPro Therapeutics, Inc., a pre-clinical stage biopharmaceutical company, announced that it will present data on the development of its inhaled treatment for cystic fibrosis (CF) at the 28(th) Annual North American Cystic Fibrosis Conference, October 9 - 11 in Atlanta. http://photos.prnewswire.com/prnvar/20120731/SF49182LOGO CF is an inherited genetic disease that affects approximately 80,000 people worldwide. OrPro's lead compound, ORP-100,...

2014-10-09 08:27:25

AUSTIN, Texas, Oct. 9, 2014 /PRNewswire/ -- International Biophysics Corporation of Austin, Texas announces its filing of U.S. patent protection for its revolutionary AffloVest®. The company has also recently confirmed exclusive ownership rights concerning the manufacture, sale and distribution of the AffloVest in its markets. The AffloVest® is the first self-contained, truly portable High Frequency Chest Wall Oscillation (HFCWO) vest available in the United States, having both...

2014-10-08 08:28:17

Collaborative Forum to Focus on Promising Advances in Drug Development, Research and Care for People with CF ATLANTA, Oct. 8, 2014 /PRNewswire-USNewswire/ -- The following is being released by the Cystic Fibrosis Foundation: WHAT: The 28th Annual North American Cystic Fibrosis Conference (NACFC), the largest collaborative forum of its kind. The conference will convene more than 4,000 cystic fibrosis research scientists, clinicians and caregivers from 20 countries to explore the latest...

2014-10-07 23:03:14

ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis closer to a cure. Cleveland, Ohio (PRWEB) October 07, 2014 The 28th Annual North American Cystic Fibrosis Conference kicks off October 9th, 2014 at the Georgia World Congress Center in Atlanta. ChanTest, the Ion Channel Expert, will be joining many others attending the three-day event that is hosted...

2014-10-06 08:28:03

Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct. 6, 2014 /PRNewswire/ -- Savara Pharmaceuticals announced today that it closed a $10 million bridge financing round to support the development of AeroVanc, the first inhaled antibiotic being developed to address the growing number of methicillin-resistant Staphylococcus aureus (MRSA) lung infections in people with cystic fibrosis (CF). Previous investors participated in the financing, and new investors include...

2014-10-02 16:27:28

NEW YORK, Oct. 2, 2014 /PRNewswire-iReach/ -- DKBmed, LLC, in collaboration with the Johns Hopkins University School of Medicine (JHUSOM), will be hosting a live satellite symposium celebrating the quarter century of progress that has occurred since mutations in the CFTR gene were first linked to cystic fibrosis (CF). Ahead of the Curve (AOTC): CFTR at 25 -- Clinician and Patient Perspectives will take place at the 28th annual North American Cystic Fibrosis Conference (NACFC) in...

2014-10-01 23:00:48

Innovative Treatment to Improve Lung Function and Antibiotic Effectiveness in CF Patients Claremont, CA (PRWEB) October 02, 2014 Cystic fibrosis (CF) is a genetic disease that causes dysfunction of the lungs and the gastrointestinal organs. In particular, very thick mucus accumulates in the lungs of CF patients. This mucus is very difficult to clear, occludes the airways, and creates an environment where bacteria can easily grow. Consequently, these patients frequently suffer from chronic...

2014-10-01 04:21:54

LAUSANNE, Switzerland, October 1, 2014 /PRNewswire/ -- Sophia Genetics, the European leader in Clinical Genomics and Next Generation Sequencing (NGS) data analysis, today launches a unique CFTR IVD Solution allowing clinicians to run full cystic fibrosis analysis in a single NGS experiment. The CE-IVD marked solution covers the identification and characterisation of all types of variants in a single NGS experiment with clinical grade analytical performance. Until now,...

Lung Flute Helps COPD Patients Breathe Easier: Study
2014-09-29 03:37:55

By Ellen Goldbaum, University at Buffalo Patients with chronic obstructive pulmonary disease (COPD) report improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute®, according to a new study by the University at Buffalo. Usually caused by smoking, COPD, which includes chronic bronchitis and emphysema, is the third leading cause of death in the US. The Lung Flute, manufactured by Medical Acoustics, (Buffalo), uses sound waves to break up...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related